美国FDA药品审评部门周五表示，已成立一个委员会，负责监督该部门作出的独占权裁定并提供建议，旨在提高这些决定的明确性和一致性。
The US FDA's drug evaluation department said on Friday it has formed a board to oversee and advise on exclusivity determinations made by the department, aiming to improve clarity and consistency of those decisions.